As of April 18, 2025, Cybin (CYBN) has a market cap of $0.15 billion USD. According to our data, Cybin is ranked No.7233 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $0.15 B |
-16.67%
|
Dec 31, 2024 | $0.19 B |
-43.39%
|
Dec 29, 2023 | $0.33 B |
38.05%
|
Dec 30, 2022 | $0.24 B |
-75.25%
|
Dec 31, 2021 | $0.96 B |
-19.46%
|
Dec 31, 2020 | $1.19 B |
13.27%
|
Dec 31, 2019 | $1.05 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() COMPASS Pathways
CMPS
|
$0.29 B |
-0.000 M
|
![]() UK
|
![]() Mind Medicine
MNMD
|
$0.43 B |
0.000 M
|
![]() USA
|
![]() Atai Life Sciences
ATAI
|
$0.29 B |
-0.000 M
|
![]() Germany
|
![]() GH Research
GHRS
|
$0.56 B |
0.000 M
|
![]() Ireland
|
![]() Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
![]() USA
|
![]() Neonode
NEON
|
$0.15 B |
0.000 M
|
![]() Sweden
|
Market Cap | = | CYBN Stock Price | * | CYBN Shares Outstanding |
= | $7.35 | * | 21.02 M | |
= | $0.15 B |